novo nordisk lawsuit semaglutide is suing U.S. telehealth company Hims and Hers, alleging patent infringement over its planned release of a knockoff version of its Wegovy weight loss pill. Hims and Hers is pushing back, Novo asks FDA to prevent

The GOAL-HF1 trial, investigating the safety and efficacy of ghrelin in patients with HFrEF, is currently ongoing and represents an important step toward determining the therapeutic potential of ghrelin in HF

Please consult with us if you: Are pregnant or breastfeeding Have underlying health conditions Are taking certain medications Can this be part of a regular routine

Choosing Best Ultra Pure BPC-157 UK 2026 - Complete Multi-Vial Research Set can be overwhelming most research sources disappoint on batch consistency

Thyroid-associated ophthalmopathy and ferroptosis: a review of pathological mechanisms and therapeutic strategies